13F Insight
DOSSIER · 13F-HR · Q2 2026

HARVEY CAPITAL MANAGEMENT INC

$469M in tracked AUM across 78 positions as of Q2 2026.

HC
CIK 0001119032 · last filed Jun 30, 2026
Total AUM
$469M
as of Q2 2026
Holdings
78
—
positions
Whale Score
60
60
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Portfolio Overview

Harvey Capital Management Inc. has reported a significant contraction in portfolio value for the quarter ended September 30, 2025. The total assets under management (AUM) decreased by 43.1%, dropping from $426.91 million to $243.05 million. This reduction is not solely attributable to market performance but is largely the result of substantial capital deployment changes, evidenced by the exit from 28 positions and the initiation of 22 new ones. The portfolio currently con...

Key Holdings

The portfolio is heavily top-heavy, with a strong bias toward the technology sector, specifically artificial intelligence infrastructure. The single largest position is NVIDIA Corp (NVDA), comprising 32.84% of the portfolio ($79.81M). This represents an exceptionally high concentration in a single volatile asset, signaling an aggressive conviction in the AI trade. Following NVDA, the firm maintains a dual-class structure position in Alphabet (GOOG and GOOGL), which collectively account for 18.5% of the portfolio ($44.97M), further reinforcing the technology and communication services tilt.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
NVDA
NVIDIA CORP
$80M402K16.5%02
GOOG
ALPHABET INC
$45M128K9.3%03
AMZN
AMAZON.COM INC
$37M156K7.6%04
AAPL
APPLE COMPUTER INC
$28M98K5.8%05
MSFT
MICROSOFT CORP
$17M46K3.5%06
GOOGL
ALPHABET INC CAP STK
$16M44K3.3%07
URI
UNITED RENTALS INC
$14M12K2.9%08
JPM
JP MORGAN CHASE
$12M37K2.5%09
HALO
HALOZYME THERAPEUTICS INC
$11M146K2.4%10
BBIO
BRIDGEBIO PHARMA
$10M139K2.1%

Filing history

2026Q2Jun 30
$486M▲ 10.8%
92 positionsView →2026Q1Mar 31
$439M▼ 6.4%
88 positionsView →2025Q4Dec 31
$469M▲ 92.9%
78 positionsView →2025Q3Sep 30
$243M▼ 43.1%
44 positionsView →2025Q2Jun 30
$427M▲ 11.7%
79 positionsLocked2025Q1Mar 31
$382M▼ 10.0%
78 positionsLocked2024Q4Dec 31
$425M▲ 6.2%
80 positionsLocked2024Q3Sep 30
$400M▲ 5.1%
76 positionsLocked2024Q2Jun 30
$380M▲ 11.3%
77 positionsLocked2024Q1Mar 31
$342M▲ 13.4%
77 positionsLocked2023Q4Dec 31
$301M▲ 6.1%
72 positionsLocked2023Q3Sep 30
$284M▲ 4.4%
72 positionsLocked
Showing 12 of 92